DERMISTAT Trademark

Trademark Overview

On Thursday, March 17, 2022, a trademark application was filed for DERMISTAT with the United States Patent and Trademark Office. The USPTO has given the DERMISTAT trademark a serial number of 97317530. The federal status of this trademark filing is SU - NON-FINAL ACTION - MAILED as of Thursday, May 2, 2024. This trademark is owned by BioLab Sciences, Inc.. The DERMISTAT trademark is filed in the Pharmaceutical Products category with the following description:

Processed human donor skin for the replacement of soft tissue

General Information

Serial Number97317530
Word MarkDERMISTAT
Filing DateThursday, March 17, 2022
Status807 - SU - NON-FINAL ACTION - MAILED
Status DateThursday, May 2, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 14, 2023

Trademark Statements

Goods and ServicesProcessed human donor skin for the replacement of soft tissue

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 22, 2022
Primary Code005
First Use Anywhere DateSaturday, April 2, 2022
First Use In Commerce DateSaturday, April 2, 2022

Trademark Owner History

Party NameBioLab Sciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMesa, AZ 85202
Party NameBioLab Sciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressScottsdale, AZ 85260

Trademark Events

Event DateEvent Description
Friday, February 3, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 21, 2022NEW APPLICATION ENTERED
Tuesday, March 22, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, December 19, 2022ASSIGNED TO EXAMINER
Wednesday, February 22, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 14, 2023PUBLISHED FOR OPPOSITION
Tuesday, March 14, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 9, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 6, 2023ASSIGNED TO EXAMINER
Thursday, November 9, 2023SOU EXTENSION 1 FILED
Monday, December 11, 2023ABANDONMENT - NO USE STATEMENT FILED
Monday, December 11, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Tuesday, January 16, 2024USE AMENDMENT FILED
Tuesday, January 16, 2024TEAS PETITION TO REVIVE RECEIVED
Tuesday, January 16, 2024PETITION TO REVIVE-GRANTED
Tuesday, January 16, 2024NOTICE OF REVIVAL - E-MAILED
Tuesday, January 16, 2024SOU EXTENSION RECEIVED WITH TEAS PETITION
Tuesday, January 16, 2024TEAS STATEMENT OF USE RECEIVED
Tuesday, January 16, 2024NOTICE OF REVIVAL - E-MAILED
Tuesday, February 6, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, February 6, 2024SOU EXTENSION 1 GRANTED
Tuesday, February 6, 2024STATEMENT OF USE PROCESSING COMPLETE
Wednesday, February 7, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 2, 2024NON-FINAL ACTION E-MAILED
Thursday, May 2, 2024SU - NON-FINAL ACTION - WRITTEN
Thursday, May 2, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 1, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED

Related Keywords

dermistat soft tissue replacement skin human donor processed